Literature DB >> 18563741

Deciphering the proteomic profile of Mycobacterium leprae cell envelope.

Maria Angela M Marques1, Ana Gisele C Neves-Ferreira, Erika K Xavier da Silveira, Richard H Valente, Alexander Chapeaurouge, Jonas Perales, Renato da Silva Bernardes, Karen M Dobos, John S Spencer, Patrick J Brennan, Maria Cristina V Pessolani.   

Abstract

The complete sequence of the Mycobacterium leprae genome, an obligate intracellular pathogen, shows a dramatic reduction of functional genes, with a coding capacity of less than 50%. Despite this massive gene decay, the leprosy bacillus has managed to preserve a minimal gene set, most of it shared with Mycobacterium tuberculosis, allowing its survival in the host with ensuing pathological manifestations. Thus, the identification of proteins that are actually expressed in vivo by M. leprae is of high significance in understanding obligate, intracellular mycobacterial pathogenesis. In this study, a high-throughput proteomic approach was undertaken resulting in the identification of 218 new M. leprae proteins. Of these, 60 were in the soluble/cytosol fraction, 98 in the membrane and 104 in the cell wall. Although several proteins were identified in more than one subcellular fraction, the majority were unique to one. As expected, a high percentage of these included enzymes responsible for lipid biosynthesis and degradation, biosynthesis of the major components of the mycobacterial cell envelope, proteins involved in transportation across lipid barriers, and lipoproteins and transmembrane proteins with unknown functions. The data presented in this study contribute to our understanding of the in vivo composition and physiology of the mycobacterial cell envelope, a compartment known to play a major role in bacterial pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563741     DOI: 10.1002/pmic.200700971

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  15 in total

Review 1.  Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery.

Authors:  Zhiyong Lou; Xiaoxue Zhang
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

2.  Statins increase rifampin mycobactericidal effect.

Authors:  Lívia Silva Lobato; Patrícia Sammarco Rosa; Jessica da Silva Ferreira; Arthur da Silva Neumann; Marlei Gomes da Silva; Dejair Caitano do Nascimento; Cleverson Teixeira Soares; Silvia Cristina Barbosa Pedrini; Diego Sá Leal de Oliveira; Cláudia Peres Monteiro; Geraldo Moura Batista Pereira; Marcelo Ribeiro-Alves; Mariana Andrea Hacker; Milton Ozório Moraes; Maria Cristina Vidal Pessolani; Rafael Silva Duarte; Flávio Alves Lara
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

3.  Comparative analyses of transport proteins encoded within the genomes of Mycobacterium tuberculosis and Mycobacterium leprae.

Authors:  Jiwon Youm; Milton H Saier
Journal:  Biochim Biophys Acta       Date:  2011-11-29

4.  Interaction of Mycobacterium leprae with human airway epithelial cells: adherence, entry, survival, and identification of potential adhesins by surface proteome analysis.

Authors:  Carlos A M Silva; Lia Danelishvili; Michael McNamara; Márcia Berredo-Pinho; Robert Bildfell; Franck Biet; Luciana S Rodrigues; Albanita V Oliveira; Luiz E Bermudez; Maria C V Pessolani
Journal:  Infect Immun       Date:  2013-05-13       Impact factor: 3.441

5.  Development of LepReact, a defined skin test for paucibacillary leprosy and low-level M. leprae infection.

Authors:  Malcolm S Duthie; Maria T Pena; Amit P Khandhar; Alessandro Picone; Zachary MacMIllen; Richard W Truman; Linda B Adams; Steven G Reed
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-10       Impact factor: 4.813

6.  Production of and applications for a polyclonal IgY diagnostic reagent specific for Mycobacterium avium subsp. paratuberculosis.

Authors:  Sung Jae Shin; Seung-Sub Lee; Elizabeth J B Manning; Michael T Collins
Journal:  J Microbiol       Date:  2009-10-24       Impact factor: 3.422

Review 7.  Catabolism and biotechnological applications of cholesterol degrading bacteria.

Authors:  J L García; I Uhía; B Galán
Journal:  Microb Biotechnol       Date:  2012-02-07       Impact factor: 5.813

8.  Implications of high level pseudogene transcription in Mycobacterium leprae.

Authors:  Diana L Williams; Richard A Slayden; Amol Amin; Alejandra N Martinez; Tana L Pittman; Alex Mira; Anirban Mitra; Valakunja Nagaraja; Norman E Morrison; Milton Moraes; Thomas P Gillis
Journal:  BMC Genomics       Date:  2009-08-25       Impact factor: 3.969

9.  The challenge of producing skin test antigens with minimal resources suitable for human application against a neglected tropical disease; leprosy.

Authors:  Becky L Rivoire; Stephen TerLouw; Nathan A Groathouse; Patrick J Brennan
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29

10.  Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study.

Authors:  Becky L Rivoire; Nathan A Groathouse; Stephen TerLouw; Kapil Dev Neupane; Chaman Ranjit; Bishwa Raj Sapkota; Saraswoti Khadge; Chhatra B Kunwar; Chatra B Kunwar; Murdo Macdonald; Rachel Hawksworth; Min B Thapa; Deanna A Hagge; Melinda Tibbals; Carol Smith; Tina Dube; Dewei She; Mark Wolff; Eric Zhou; Mamodikoe Makhene; Robin Mason; Christine Sizemore; Patrick J Brennan
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.